HTAC PRELIMINARY RECOMMENDATION ON abiraterone acetate(250mg tablet) and enzalutamide (40mg soft gel capsule)
[DEPARTMENT CIRCULAR No. 2022 – 0291] Amendment to the Department Circular 2022-0291 “Health Technology Assessment Council (HTAC) Recommendation to include Potassium Citrate 15 mEq Extended Release (ER) Tablet in the Philippine National Formulary”
DEPARTMENT CIRCULAR No. 2022 – 0491: Nomination to the Health Technology Assessment Council (HTAC) Core Committee and Subcommittee Members
[ADVISORY] DRAFT GUIDELINES ON THE APPLICATION OF PHILIPPINE SOCIAL VALUES ON HEALTH TECHNOLOGY ASSESSMENT for public consultation from 21 September to 05 October 2022
[DEPARTMENT CIRCULAR No. 2022 – 0486] Health Technology Assessment Council (HTAC) Recommendation for the Non-inclusion of Eribulin as Second-line Treatment of Metastatic Soft Tissue sarcoma (mSTS) the Philippine National Formulary (PNF)
[ADVISORY] DRAFT DEPARTMENT MEMORANDUM ON THE METHODOLOGY OF PEMDL DRAFT INTERIM GUIDELINES ON THE PROCESS AND METHODS FOR THE SELECTION OF MEDICAL DEVICES FOR INCLUSION IN THE PHILIPPINE ESSENTIAL MEDICAL DEVICE LIST (PEMDL) FOR COMMENTS UNTIL 21 SEPTEMBER 2022
